𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma group

✍ Scribed by Prof. Dr. H. M. Pinedo; V. H. C. Bramwell; H. T. Mouridsen; R. Somers; C. P. J. Vendrik; A. Santoro; J. Buesa; Th. Wagener; A. T. van Oosterom; J. A. M. van Unnik; R. Sylvester; M. de Pauw; D. Thomas; O. Bonadonna

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
671 KB
Volume
53
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Soft tissue sarcomas in infants younger
Soft tissue sarcomas in infants younger than 1 year of age: A report of the German soft tissue sarcoma study group (CWS-81)
✍ Koscielniak, E. ;Harms, D. ;Schmidt, D. ;Ritter, J. ;Keim, M. ;Riehm, H. ;Treune πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 485 KB

Of 357 patients with soft tissue sarcomas (STSs) who were registered between 1981 and 1986 in the CWS-81 study, 21 (5.8%) were younger than 1 year of age. Six cases were probably of congenital origin since they were diagnosed in the 1st month of life. There was no difference in clinical grouping (st

Phase II study of a protracted irinoteca
Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma
✍ Gianni Bisogno; Riccardo Riccardi; Antonio Ruggiero; Giampaolo Arcamone; Arcange πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Irinotecan (CPT‐11) is a novel antineoplastic agent that takes effect by inhibiting topoisomerase I. The Italian Soft Tissue Sarcoma (STS) Committee performed a multiinstitutional Phase II study to evaluate its effect on STS. ## METHODS Over a 2‐year period between 2002